On Invalid Date, Viatris (NASDAQ: VTRS) reported Q1 2024 earnings per share (EPS) of $0.10, up 47.37% year over year. Total Viatris earnings for the quarter were $113.90 million. In the same quarter last year, Viatris's earnings per share (EPS) was $0.19.
As of Q2 2024, Viatris's earnings has grown year over year. Viatris's earnings in the past year totalled -$56.10 million.
What was VTRS's revenue last quarter?
On Invalid Date, Viatris (NASDAQ: VTRS) reported Q1 2024 revenue of $3.66 billion up 1.76% year over year. In the same quarter last year, Viatris's revenue was $3.73 billion.
What was VTRS's revenue growth in the past year?
As of Q2 2024, Viatris's revenue has grown -2.78% year over year. This is 12.76 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.98%. Viatris's revenue in the past year totalled $15.36 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.